Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · IEX Real-Time Price · USD
7.07
-0.15 (-2.08%)
May 31, 2024, 4:00 PM EDT - Market closed
Outlook Therapeutics Stock Forecast
OTLK's stock price has decreased by -76.43% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 8 analysts with 12-month price forecasts for OTLK stock have an average target of 46.43, with a low estimate of 20 and a high estimate of 100. The average target predicts an increase of 556.72% from the current stock price of 7.07.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for OTLK stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 5 | 6 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 4 | 4 | 3 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +324.33% | May 17, 2024 |
| BTIG | BTIG | Hold → Strong Buy Upgrades $50 | Hold → Strong Buy | Upgrades | $50 | +607.21% | Mar 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $1.5 → $30 | Strong Buy | Maintains | $1.5 → $30 | +324.33% | Mar 25, 2024 |
| Chardan Capital | Chardan Capital | Hold → Strong Buy Upgrades $60 | Hold → Strong Buy | Upgrades | $60 | +748.66% | Feb 15, 2024 |
| Guggenheim | Guggenheim | Hold → Strong Buy Upgrades $40 | Hold → Strong Buy | Upgrades | $40 | +465.77% | Jan 25, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
9.76M
EPS This Year
-8.17
from -4.80
EPS Next Year
-2.70
from -8.17
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 16.1M | 76.7M | 358.1M | 602.7M |
| Avg | n/a | 9.8M | 65.0M | 244.2M | 413.6M |
| Low | n/a | n/a | 49.5M | 148.9M | 284.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 685.2% | 450.6% | 146.8% |
| Avg | - | - | 566.1% | 275.5% | 69.4% |
| Low | - | - | 407.5% | 128.9% | 16.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -3.78 | -2.21 | -1.67 | 3.75 | 5.48 |
| Avg | -8.17 | -2.70 | -1.62 | 3.64 | 5.32 |
| Low | -11.58 | -3.16 | -1.56 | 3.50 | 5.12 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 50.5% |
| Avg | - | - | - | - | 46.2% |
| Low | - | - | - | - | 40.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.